Migratory superficial thrombophlebitis is seen in-
**Core Concept**
Migratory superficial thrombophlebitis is a clinical manifestation of a systemic condition characterized by the formation of blood clots in superficial veins that migrate over time. This phenomenon is often associated with an underlying inflammatory or neoplastic process.
**Why the Correct Answer is Right**
Migratory superficial thrombophlebitis is commonly seen in patients with **Trousseau syndrome**, a paraneoplastic syndrome associated with malignancies, particularly pancreatic cancer. The exact mechanism is not fully understood, but it is thought to be related to the release of pro-coagulant substances by the tumor. These substances can lead to the activation of the coagulation cascade, resulting in the formation of blood clots in superficial veins.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because migratory superficial thrombophlebitis is not typically seen in patients with deep vein thrombosis (DVT), which is a different clinical entity.
**Option B:** This option is incorrect because migratory superficial thrombophlebitis is not a characteristic feature of viral infections, such as hepatitis B or C.
**Option C:** This option is incorrect because migratory superficial thrombophlebitis is not a common manifestation of autoimmune disorders, such as lupus or rheumatoid arthritis.
**Clinical Pearl / High-Yield Fact**
Migratory superficial thrombophlebitis is a classic sign of Trousseau syndrome, and its presence should prompt a thorough investigation for underlying malignancy, particularly pancreatic cancer. This association is so strong that the presence of migratory superficial thrombophlebitis can be considered a "red flag" for pancreatic cancer.
**Correct Answer:** C. Malignancy (specifically, pancreatic cancer) is associated with migratory superficial thrombophlebitis.